TNFRSF17 and plasma cell myeloma: The result from these two xenograft bone marrow models suggested that anti-BCMA immunotoxins are very effective in eliminating BCMA expressing myeloma cells from the bone marrow of mice and represent a potential treatment option to effectively eliminate the myeloma cell in humans.